Grassley calls on HHS, FDA leaders to address mismanagement of FDA employee pay and benefits
WASHINGTON --- Senator Chuck Grassley has asked the Department of Health and Human Services and the Food and Drug Administration to respond to allegations about mismanagement of employee pay and benefits.
Grassley said that high level FDA officials and others have complained to him about paycheck errors that resulted in legal fees and sloppy record keeping and have shaken confidence in the personnel management system.
“Based on the reports that have come to me, it looks like there is more than isolated incidents of mismanagement, and it could have significant repercussions for the quality workforce that the public deserves to have at the Food and Drug Administration. The leadership of the department and the agency needs to address these issues promptly,” Grassley said.
The text of Grassley’s letter of inquiry is below.
October 28, 2008
The Honorable Michael O. Leavitt
U.S. Department of Health and Human Services
200 Independence Avenue, SW
Washington, DC 20201
The Honorable Andrew C. von Eschenbach, M.D.
U.S. Food and Drug Administration
5600 Fishers Lane
Rockville, MD 20857
Dear Secretary Leavitt and Commissioner von Eschenbach:
As a senior member of the United States Senate and Ranking Member of the
Committee on Finance (Committee), it is my responsibility to conduct oversight into the
actions of the executive branch, including activities at the Department of Health and Human
Services (HHS) and the Food and Drug Administration (FDA or Agency). In that capacity, I
am very concerned about allegations I received regarding mismanagement of FDA employee
pay and benefits.
My Committee staff has spoken to a number of FDA employees, including high level
officials, regarding this matter, and I am very concerned that payroll problems are adversely
affecting employee morale and work performance at the FDA. The cases that have been
reported to me suggest serious vulnerabilities in the wage and benefit management system.
For example, I was told that an FDA employee went to the emergency room in the middle of
the night with a sick child, only to discover that the Agency had incorrectly terminated him,
thus cancelling his health insurance benefits. I also learned that on at least two occasions
employees may have been mistakenly overpaid by several thousand dollars, resulting in the
receipt of threatening debt collection letters, misstatement of income taxes, and costly
expenditures on attorneys and accountants. Such errors may also leave the Agency open to
costly legal actions. In yet another case, I was informed that a brand new employee at the
FDA was not paid for several pay periods because the employee “fell out of the system.”
My staff also spoke to a senior medical officer who expressed sincere concern over
the FDA’s ability to adequately address employees’ complaints. Specifically, the medical
officer stated that the wage and benefit errors absolutely “affect the quality of work,” and that
even though his/her complaint has been technically resolved, s/he has little confidence that
the problems will not re-emerge upon his/her retirement. In the same vein, another senior
medical officer confessed that his/her pay errors have caused him/her “an enormous amount
of stress,” and that the errors are the only reason that s/he would leave the FDA for the
Such misgivings likely contribute to turnover at the FDA, despite the massive hiring
initiative the Agency undertook earlier this year. Though the FDA recently met its 1,300
new employee hiring goal, I understand that over 40% of those new hires are simply filling
vacancies created by retirement and normal attrition.
Employees are the FDA’s lifeblood, and HHS and FDA have an absolute
responsibility to properly manage their compensation. In an effort to understand the scope of
the payroll problems, I request that HHS and the FDA provide my staff with data on all wage
or benefit-related complaints filed by FDA employees since January 1, 2006. In your
production, please include the following for each complaint:
• summary of the complaint;
• date of the complaint;
• actions taken to rectify the problem;
• current status of the complaint; and
• date the issue was resolved.
Please also provide my staff with an analysis of the hiring surge, including:
• net increase or decrease in staff by center, from January 1, 2008 to the present (please
distinguish between part-time and full-time employees);
• number of new Center for Drug Evaluation and Research (CDER) employees for
whom CDER is their first assignment within the FDA; and
• number of new CDER employees who transferred to CDER from another FDA center
In addition, it is my understanding that until about six years ago, FDA had its own
human resources office and managed its own employees’ wages and benefits. I was told that
the Program Support Center (PSC) within HHS currently handles human resources matters
for HHS and its agencies. Furthermore, I was informed by FDA employees that the Defense
Finance and Accounting Services (DFAS) is responsible for processing pay transactions for
the Agency. Please describe in detail the roles and responsibilities of PSC and DFAS with
respect to management of pay and benefits for FDA employees. Additionally, please provide
• a detailed description of the performance goals and metrics related to payroll
processing, error rates, and error correction used to measure the performance of the
PSC and any related contractors;
• a copy of any pay or benefit error reports from January 2006 to the present prepared
by FDA, HHS, PSC or any other contractors;
• a copy of any evaluation(s) or analysis(es) of the performance of the PSC and any
related contractors from January 2002 to the present conducted by HHS and/or third
• a copy of any service level agreements or other contracts or arrangements with PSC
and/or other contractors related to payroll processing and error correction.
Thank you for your attention to this important matter.
Charles E. Grassley
Next Article Previous Article